Tantum Verde, tablets 3 mg 40 pcs

Sore throat, Stomatitis, Gum inflammation, Tonsillitis, Angina, Oral inflammation, Pharyngitis, LaryngitisSymptomatic therapy of pain syndrome of inflammatory diseases of the mouth and ENT-organ (various etiology):

• Gingivitis, glossitis, stomatitis (including. After radiation and chemotherapy)
• pharyngitis, laryngitis, tonsillitis;
• candidosis of the oral mucosa (in combination therapy);
• calculous inflammation of the salivary glands;
• after surgical interventions and trauma (tonsillectomy, jaw fractures)
• after dental treatment and extraction;
• parodontosis;

In infectious and inflammatory diseases requiring systemic treatment, Tantum® Verde should be used as part of combination therapy.

Indications

Symptomatic treatment of pain syndrome of inflammatory diseases of the oral cavity and ENT organs (of various etiologies):
gingivitis, glossitis, stomatitis (including after radiation and chemotherapy);
pharyngitis, laryngitis, tonsillitis;
candidiasis of the oral mucosa (as part of combination therapy);
calculous inflammation of the salivary glands;
after surgical interventions and injuries (tonsillectomy, jaw fractures)
after treatment and tooth extraction;
periodontal disease;
For infectious and inflammatory diseases requiring systemic treatment, it is necessary to use Tantum® Verde as part of combination therapy.

Pharmacological effect

non-steroidal anti-inflammatory drug

Special instructions

When using the drug Tantum® Verde, hypersensitivity reactions may develop. In this case, it is recommended to stop treatment and consult a doctor to prescribe appropriate therapy.

In a limited number of patients, the presence of ulcers in the throat and mouth may indicate a more serious condition. If symptoms persist for more than 3 days, you should consult your doctor.

Active ingredient

Benzydamine

Composition

For one lozenge:

Pregnancy

Tantum® Verde should not be used during pregnancy or breastfeeding.

Contraindications

Hypersensitivity to benzydamine or other components of the drug;
fructose intolerance;
children under 6 years of age;
phenylketonuria
With caution
Hypersensitivity to acetylsalicylic acid or other non-steroidal anti-inflammatory drugs, bronchial asthma (including a history).

Side Effects

World Health Organization (WHO) side effect frequency classification:
very often – ≥1/10;
often – from ≥ 1/100 to < 1/10;
uncommon – from ≥1/1000 to <1/100;
rarely – from ≥1/10000 to <1/1000;
very rare – <1/10000;
frequency unknown—cannot be estimated from available data.

Interaction

No interaction studies have been conducted with other drugs.

Overdose

Currently, no cases of overdose of Tantum® Verde have been reported.

Symptoms: when using the drug in accordance with the instructions for use, an overdose is unlikely. If the drug is accidentally ingested, the following symptoms may occur: vomiting, abdominal cramps, anxiety, fear, hallucinations, convulsions, ataxia, fever, tachycardia, respiratory depression.

Treatment: symptomatic; cleanse the stomach by inducing vomiting or flushing the stomach using a gastric tube (under medical supervision); provide medical supervision, supportive care and necessary hydration. No antidote is known.

Storage conditions

At a temperature not exceeding 25° C, in a place protected from light.

Shelf life

4 years.

Manufacturer

Aziende Chimique Riunite Angelini Francesco A.C.R.A., Italy